Cargando…
The novel fluorinated 2-nitroimidazole hypoxia probe SR-4554: reductive metabolism and semiquantitative localisation in human ovarian cancer multicellular spheroids as measured by electron energy loss spectroscopic analysis.
The novel fluorinated 2-nitroimidazole SR-4554 is undergoing preclinical development as a magnetic resonance spectroscopy and imaging probe for hypoxic tumour cells. We have used electron energy loss spectroscopic analysis (EELS) to show selective reduction and differential subcellular localisation...
Autores principales: | Aboagye, E. O., Lewis, A. D., Johnson, A., Workman, P., Tracy, M., Huxham, I. M. |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
1995
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2034013/ https://www.ncbi.nlm.nih.gov/pubmed/7640211 |
Ejemplares similares
-
The relationship between tumour oxygenation determined by oxygen electrode measurements and magnetic resonance spectroscopy of the fluorinated 2-nitroimidazole SR-4554.
por: Aboagye, E. O., et al.
Publicado: (1998) -
A phase I study of the nitroimidazole hypoxia marker SR4554 using (19)F magnetic resonance spectroscopy
por: Lee, C P, et al.
Publicado: (2009) -
Use of a high frequency ultrasound microscope to image the action of 2-nitroimidazoles in multicellular spheroids.
por: Bérubé, L. R., et al.
Publicado: (1992) -
Evaluating nanoparticle localisation in glioblastoma multicellular tumour spheroids by surface enhanced Raman scattering
por: McCabe, Samantha M., et al.
Publicado: (2023) -
Linking hypoxia, DNA damage and proliferation in multicellular tumor spheroids
por: Riffle, Stephen, et al.
Publicado: (2017)